Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10

    • Methicillin Sodium Salt: Atomic Evidence for Cell Wall In...

    2026-02-21

    Methicillin Sodium Salt: Atomic Evidence for Cell Wall Inhibition

    Executive Summary: Methicillin sodium salt (CAS No. 132-92-3) is a penicillinase-resistant, semi-synthetic β-lactam antibiotic optimized for inhibiting bacterial cell wall synthesis in gram-positive bacteria, especially MSSA, by targeting penicillin-binding proteins (PBPs) and transpeptidase enzymes (Santa Maria et al. 2017). Its minimum inhibitory concentration (MIC) for MSSA ranges from 0.125 to 2 μg/mL, while MRSA strains show resistance with MIC >8 μg/mL (Methoxy-X04). The sodium salt is highly soluble in DMSO (≥14.4 mg/mL) and is routinely used in agar or broth dilution assays for antibiotic susceptibility testing. APExBIO supplies high-purity methicillin sodium salt (SKU C3238) for reproducible infection modeling (APExBIO). Due to the rise of MRSA, clinical use has declined, but the compound remains crucial for laboratory benchmarking and resistance research.

    Biological Rationale

    Methicillin sodium salt is a semi-synthetic derivative of penicillin designed to resist degradation by bacterial penicillinase (β-lactamase) enzymes. Its chemical structure includes a 2,6-dimethoxyphenyl group, conferring stability to β-lactamase action (Methoxy-X04). The agent is primarily used to investigate Staphylococcus aureus infections, differentiate MSSA from MRSA in vitro, and serve as a reference standard in drug susceptibility assays (MecillinamSupplier). The sodium salt form allows for enhanced solubility and precise dosing in both clinical and research settings.

    Mechanism of Action of Methicillin sodium salt

    Methicillin sodium salt acts as a bacterial cell wall synthesis inhibitor by targeting penicillin-binding proteins (PBPs), particularly the transpeptidase enzyme required for peptidoglycan cross-linking (Santa Maria et al. 2017). The antibiotic binds covalently to the serine residue in the active site of PBPs, blocking the cross-linking of N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) chains in the bacterial wall (LimaprostCas). This results in cell wall weakening and eventual bacteriolysis in dividing gram-positive bacteria. Resistance in MRSA is mediated by the mecA gene, which encodes a low-affinity PBP2a that methicillin cannot efficiently inhibit.

    Evidence & Benchmarks

    This article extends the molecular and assay insights of LimaprostCas (2022) by providing updated, quantitative resistance and solubility benchmarks and clarifies the clinical and research context versus MecillinamSupplier (2021), which focused on model selection for MSSA assays.

    Applications, Limits & Misconceptions

    Applications: Methicillin sodium salt is widely used for:

    • Antibiotic susceptibility testing of gram-positive cocci, especially to distinguish MSSA from MRSA (MecillinamSupplier).
    • Benchmarking antibiotic efficacy in infection model systems (DisodiumSalt).
    • Research on mechanisms of β-lactam resistance and cell wall biosynthesis (Santa Maria et al. 2017).

    Limits:

    • Not active against MRSA due to mecA-encoded PBP2a (Santa Maria et al. 2017).
    • Clinical use has been largely replaced by other antibiotics due to widespread MRSA prevalence (Methoxy-X04).
    • Long-term storage of aqueous solutions is not recommended; stability is best at -20°C (APExBIO).

    Common Pitfalls or Misconceptions

    • Assuming efficacy against MRSA: Methicillin sodium salt is ineffective against MRSA strains that express PBP2a.
    • Using expired or improperly stored solutions: Potency rapidly decreases if not stored at recommended -20°C conditions.
    • Overlooking cross-reactivity: There is a risk of allergic reaction in patients sensitive to other β-lactam antibiotics.
    • Confusing MIC values between MSSA and MRSA: MIC >8 μg/mL is a clear indicator of resistance, not partial efficacy.
    • Applying clinical dosages directly to in vitro models: Laboratory protocols require lower, precisely titrated concentrations.

    Workflow Integration & Parameters

    Stock Preparation: Dissolve methicillin sodium salt at ≥14.4 mg/mL in DMSO for master stocks. Filter-sterilize for cell culture or microbial assays (APExBIO).

    Susceptibility Testing: Use concentrations from 0.06 to 16 μg/mL in standardized broth or agar dilution assays, incubate at 35–37°C for 16–20 h (MecillinamSupplier).

    Clinical Protocols: For intravenous use, adult dosing ranges from 4 to 12 g per day in divided doses, aiming for peak serum levels of 10–40 μg/mL. Clinical use is now rare due to resistance (Methoxy-X04).

    Storage: Store powder at -20°C in a desiccated environment; avoid repeated freeze-thaw cycles. Discard aqueous solutions after use.

    For researchers seeking high-purity standards, the Methicillin sodium salt C3238 kit from APExBIO is validated for reproducible results in both cell-based and microbiological models.

    Conclusion & Outlook

    Methicillin sodium salt remains a critical tool for benchmarking MSSA infection models and elucidating β-lactam antibiotic mechanisms, despite its clinical decline. Its well-characterized action on penicillin-binding proteins and defined resistance markers make it a gold standard in both susceptibility testing and resistance modeling. With the continued emergence of MRSA and evolving resistance pathways, the compound is indispensable for translational research and assay development. APExBIO’s C3238 formulation provides a reproducible, research-grade standard for gram-positive bacterial infection studies.